Clinical Trial Update: A Phase II Multi-centre, Extension Study to Investigate the Long Term Safety of ONO-2506PO in Patients Diagnosed With Amyotrophic Lateral Sclerosis (ALS) [Phase 2]

View source ↗

Summary

This clinical trial update notes completion of a Phase II multi-centre extension study evaluating the long-term safety of ONO-2506PO in patients with amyotrophi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• ONO-2506PO

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Amyotrophic Lateral Sclerosis (ALS) | Phase 2 | Status: COMPLETED